MAPT and Alzheimer disease: Other downstream effects of CEBPB signaling include cytokine production, which causes neuroinflammation, as well as upregulation of δ-secretase, a key mediator of AD onset and progression which acts by cleaving both tau and Aβ to trigger formation of plaques and neurofibrillary tangles (Wang et al., 2018).